Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 055 349.2 |
96 | EP file number | EAKZ | 17 85 5006.7 |
86 | WO file number | WAKZ | PCT/CN2017/104506 |
97 | EP publication number | EPN | 3502105 |
87 | WO publication number | WPN | 2018059556 |
54 | Designation/title | TI | POLYMORPHE FORM VON KINASEHEMMERVERBINDUNG, PHARMAZEUTISCHE ZUSAMMENSETZUNG DAMIT UND HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG DAVON |
51 | IPC main class | ICM (ICMV) | C07D 403/14 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/404 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Sep 29, 2017 |
96 | EP application date | EAT | Sep 29, 2017 |
86 | WO application date | WAT | Sep 29, 2017 |
43 | Date of first publication | OT | Apr 5, 2018 |
| Date of publication of grant | PET | Mar 30, 2022 |
71/73 | Applicant/owner | INH | Equinox Sciences, LLC, Wilmington, DE, US |
72 | Inventor | IN | LIANG, Congxin, Palm Beach Gardens FL 33410, US; XIE, Lihua, Shanghai 201203, CN |
74 | Representative | VTR | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
| Address for service | | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 201610866253 Sep 29, 2016
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003502105A1 Searchable text:
EP000003502105A1 Original document:
EP000003502105B1 Searchable text:
EP000003502105B1 Original document:
WO002018059556 Searchable text:
WO002018059556 |
43 | Date of first publication | EVT | Apr 5, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Jun 5, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 20, 2024 (Show all update days)(Hide all update days)- Sep 20, 2024
- Jul 26, 2024
- St.36: changed (technical change)
- Jul 11, 2024; Jun 13, 2024; May 2, 2024; Sep 22, 2023; Mar 23, 2023; Feb 16, 2023; Sep 23, 2022; Jun 15, 2022; May 12, 2022; Apr 14, 2022; Mar 10, 2022; Aug 23, 2019; Jul 6, 2019; Jun 6, 2019
- Historical data not available for this/these date(s)
- Jun 5, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | May 11, 2022 |
| Issue number | HN | 24 |
| Year | PJ | 2022 |
| Publication date | VT | Jun 15, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Equinox Sciences, LLC, Wilmington, DE, US |
71/73 | Previous applicant/owner | INHF | Betta Pharmaceuticals Co., Ltd., Hangzhou, Zhejiang, CN, Equinox Sciences, LLC, Wilmington, DE, US |
| Date of update of the procedure | REGT | Jun 15, 2022 |